Near-Term Outlook Muted on Pharma Stocks: Prashasta Seth
PUBLISHED ON: October 28, 2015 | Duration: 5 min, 35 sec
Prashasta Seth, CEO of IIFL AMC, said pharma companies are facing pricing pressure in the US and many companies are facing regulatory issues. Until clarity emerges on these two fronts, pharma stocks may remain rangebound, he added.
